Journal Section:
Commentary
References
1.
Tang
WHW
, Kitai
T
, Hazen
SL
. Gut microbiota in cardiovascular health and disease
. Circ Res
. 2017
;120
(7
):1183
–96
. 2.
Kitai
T
, Kohsaka
S
, Kato
T
, Kato
E
, Sato
K
, Teramoto
K
, et al. JCS/JHFS 2025 guideline on diagnosis and treatment of heart failure
. Circ J
. 2025
. 3.
Mamic
P
, Snyder
M
, Tang
WHW
. Gut microbiome-based management of patients with heart failure: JACC review topic of the week
. J Am Coll Cardiol
. 2023
;81
(17
):1729
–39
. 4.
Mayerhofer
CCK
, Kummen
M
, Holm
K
, Broch
K
, Awoyemi
A
, Vestad
B
, et al. Low fibre intake is associated with gut microbiota alterations in chronic heart failure
. ESC Heart Fail
. 2020
;7
(2
):456
–66
. 5.
Lupu
VV
, Adam Raileanu
A
, Mihai
CM
, Morariu
ID
, Lupu
A
, Starcea
IM
, et al. The implication of the gut microbiome in heart failure
. Cells
. 2023
;12
(8
):1158
. 6.
Crisci
G
, Israr
MZ
, Cittadini
A
, Bossone
E
, Suzuki
T
, Salzano
A
. Heart failure and trimethylamine N-oxide: time to transform a “gut feeling” in a fact
. ESC Heart Fail
. 2023
;10
(1
):1
–7
. 7.
Challa
AA
, Lewandowski
ED
. Short-chain carbon sources: exploiting pleiotropic effects for heart failure therapy
. JACC Basic Transl Sci
. 2022
;7
(7
):730
–42
. 8.
Liu
W
, Wang
L
, Ou
J
, Peng
D
, Zhang
Y
, Chen
W
, et al. Gut microbiota metabolites and chronic diseases: interactions, mechanisms, and therapeutic strategies
. Int J Mol Sci
. 2025
;26
(8
):3752
. 9.
Zhao
S
, Dan
L
, Huang
R
, Shen
Z
, Huang
D
, Wu
P
, et al. Decoding the impact of gut microbiota on heart failure
. Genes Dis
. 2025
:101592
. 10.
Leshem
A
, Horesh
N
, Elinav
E
. Fecal microbial transplantation and its potential application in cardiometabolic syndrome
. Front Immunol
. 2019
;10
:1341
. 11.
Wang
Z
, Roberts
AB
, Buffa
JA
, Levison
BS
, Zhu
W
, Org
E
, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis
. Cell
. 2015
;163
(7
):1585
–95
. 12.
Mirhosseini
SM
, Rezaei
M
, Soltanipur
M
, Yarmohammadi
H
, Soroush
E
, Taromiha
A
, et al. Gut microbiome composition and one-year survival outcomes among patients with reduced ejection fraction heart failure
. Cardiology
. 2025
:1
–20
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended...
© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.